Funding Opportunities
Funding Opportunities

Since 1981, AFAR has provided more than $178 million to more than 4,100 talented investigators and students. To learn more about each grant, click below or contact the AFAR grant program staff at

The New Investigator Awards in Alzheimer's Disease

Please note: The 2018 awards are closed and applications are no longer being accepted. Moving forward, this funding opportunity will not be offered. For future funding opportunities, please view Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03).


The Program

Funded by The Rosalinde and Arthur Gilbert Foundation, the major goal of this partnership program is to support important research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, and treatment of Alzheimer's disease. The program also serves to encourage junior investigators in the United States and Israel to pursue research and academic careers in the neurosciences, Alzheimer's disease and healthy brain aging in particular.

The program will fund applications in basic, translational and clinical research related to Alzheimer’s disease and healthy brain aging. Research that shows high promise for translating basic biomedical knowledge to prevention or new treatments is of particular interest.

Examples of promising areas of research include, but are not limited to:

  • Genetic and environmental risk/protective factors
  • Cellular and molecular pathways
  • Cardiovascular and cerebrovascular factors
  • Neuro-inflammation
  • Neuroimaging and other biomarkers
  • Cellular, animal and in silico models
  • Diagnostic and prognostic markers
  • Exercise, nutrition, and dietary factors
  • Drug discovery  and other therapeutics
  • Learning and memory
  • The biology and pathobiology of synapses
  • Neurogenesis, neural and glial progenitors

It is anticipated that up to 3 grants of $50,000 each will be awarded in 2018, with the stipulation that 1:1 matching funds are contributed by the applicant’s institution, bringing the total award amount to $100,000. Up to 8% of funds may be budgeted for overhead or indirect costs (not to exceed $3,704). Indirect cost on the matching funds (minimum of $46,296 in direct cost) is not required. The matching funds may only be used to support the New Investigator in Alzheimer’s Disease project. Matching funds can either be in cash and/or in-kind (i.e. the fair value of non-cash contributions to the project.) 

Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Funding will begin October 1, 2018.


The applicant must be an independent investigator in the United States or Israel with independent research space as described in the Institutional Commitment Form completed by the Dean or Department Chair, and must be no more than 10 years beyond start of postdoctoral research training as of October 1, 2018. Exceptions to the ten year rule may be requested for unusual circumstances by emailing an NIH-style biosketch to AFAR at at least one week prior to the submission deadline. The proposed research must be conducted at any type of not-for-profit setting in the United States or Israel.

The New Investigator Awards in Alzheimer's Disease do not provide support for:

  • Postdoctoral fellows in the laboratory of a senior investigator
  • Investigators who have already received major extramural funding (such as an R01 or NSF equivalent grant) prior to and up until the start date of the award
  • Senior faculty, i.e. at the rank of Associate Professor level or higher
  • Federal employees
  • Applicants who are conducting research at a for-profit institution, or at an institution outside of the United States or Israel

Review Guidelines

Five criteria are used to determine the merit of an application:

  • Scientific merit of the proposed research;
  • Qualifications of the applicant;
  • Relevance of the proposal to Alzheimer's disease or healthy brain aging;
  • Excellence of the research environment;
  • Likelihood that the project will advance the applicant's research career in Alzheimer's Disease or healthy brain aging

The scientific merit of the proposed research is the most important criterion, while the other four criteria are equally weighted. For one of the awards, priority may be given to an investigator with a research project that has great translational potential provided the application is deemed to meet the highest standards set by AFAR's Review Committee.

If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.

Application Procedures

The deadline for receipt of all Letters of Intent is April 13, 2018 at 5:00 p.m. EST. Please refer to the New Investigator LOI instructions. Incomplete LOIs cannot be considered.  All Letters of Intent and Institutional Commitment Forms must be submitted through to The Letters of Intent will be reviewed by a committee.  Applicants will be notified by mid-May, and a subset of applicants will be invited to submit a full application by late June.

Click here for our Frequently Ask Questions page.

All LOI candidates who are invited to submit applications must have it endorsed by their institution. Final awards are announced by late August. The award start date is October 1, 2018. AFAR will not provide reviewer critiques to any applicants at any review level.

Reporting Requirements

Final narrative and financial reports are required within three months following the end date of the award. Guidelines for submitting reports as well as other administrative questions can be found here.

Annual Meeting

The award recipients are expected to attend the AFAR Grantee Conference which convenes AFAR grant recipients, mentors and leaders in the field to review and disseminate the research progress of the grantees and their findings. The meeting encourages networking, facilitates collaborations, and enhances the development of leadership. In addition, grant recipients of the New Investigator Awards in Alzheimer's are expected to attend a special session at the grantee conference.

The Rosalinde and Arthur Gilbert Foundation

The Rosalinde and Arthur Gilbert Foundation is committed to providing resources to organizations that promote and improve health, education, economic, and cultural opportunities to communities in California, the U.S. and Israel.

The Rosalinde and Arthur Gilbert Foundation supports:

  • College access and retention in Greater Los Angeles
  • Education, economic development, and scientific research in Israel
  • Diabetes prevention and healthy land use in Greater Los Angeles
  • Alzheimer’s Disease research in the U.S and Israel and caregiver support in the U.S.
  • Cultural organizations and arts education programs in Greater Los Angeles
  • Jewish Life organizations in Greater Los Angeles
  • Programs at UC Berkeley and UCLA that intersect with the Foundation’s mission and objectives.

To leverage its commitments, The Rosalinde and Arthur Gilbert Foundation partners with other funders, government agencies, and local and international philanthropists.



More on the New Investigators